Compare ZLAB & ITW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | ITW |
|---|---|---|
| Founded | 2013 | 1912 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 83.0B |
| IPO Year | 2017 | 1994 |
| Metric | ZLAB | ITW |
|---|---|---|
| Price | $24.80 | $268.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 11 |
| Target Price | $49.60 | ★ $263.45 |
| AVG Volume (30 Days) | 942.7K | ★ 977.0K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 5.50 |
| Revenue | $460,156,000.00 | ★ $14,768,000,000.00 |
| Revenue This Year | $9.75 | $4.27 |
| Revenue Next Year | $26.03 | $3.44 |
| P/E Ratio | ★ N/A | $48.76 |
| Revenue Growth | ★ 15.33 | 3.17 |
| 52 Week Low | $15.96 | $238.82 |
| 52 Week High | $34.72 | $303.16 |
| Indicator | ZLAB | ITW |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 36.67 |
| Support Level | $16.84 | $263.55 |
| Resistance Level | $25.28 | $274.54 |
| Average True Range (ATR) | 0.81 | 4.60 |
| MACD | -0.45 | -1.32 |
| Stochastic Oscillator | 24.35 | 23.78 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one-fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test and measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers and fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.